Skip to content

DMAC - DiaMedica Therapeutics Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchD

DiaMedica Therapeutics Inc

DMAC · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

D

DMACDiaMedica Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $10.42
52-wk low: $5.14
Prev close: $8.20
Mkt cap: $367.2M
Beta: 0.97
P/S: 66.7x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$29.9M

MI
Millennium
Israel Englander · Q2 2026 13F
$6.0M
position
CI
Citadel
Ken Griffin · Q2 2026 13F

Earnings

Reported Aug 10, 2026

Earnings landed in line with what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $367M

Valuation

P/S66.68
P/B9.27

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: DMAC
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $367.23M
Beta: 0.97

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

9.3x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-114.6%

$1.0M

position

SQ

Squarepoint

Q2 2026 13F

$1.0M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for DMAC

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.19+0.0%

-$0.19 expected

Next report

What the street expects next

EPS expected

-$0.21

-$0.24 to -$0.19

Revenue expected

$0.00

4 analysts

Last 30 days

2up1down

Analysts raising estimates

Estimate drift

0.01

Change in 30 days

-114.6%

ROA-64.1%

Growth

Beta0.97